neostem inc (NBS:NASDAQ CM)
Robin L. Smith M.D., MBA,Ro
Executive Chairman, Neostem, Inc.
|Age||Total Calculated Compensation||This person is connected to 66 board members in 7 different organizations across 9 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Robin L. Smith, M.D., MBA, Ro, served as an Executive Chairman of Neostem, Inc. and served as its and Chief Executive Officer since June 2, 2006. Dr. Smith served as the Chief Operating Officer - Ip2m Division and Senior Vice President - Ip2m Division at Dialog Group, Inc. He serves as Member of Advisory Board at Wellfleet Partners Investment Arm. They serves as Member of Medical Advisory Board at House of Brussels Chocolates Inc. He serves as Member of Advisory ...
420 Lexington AvenuePhone: 212-584-4180
New York, New York 10170
Board Members Memberships*
Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Governance Committee
University of Pennsylvania - The Wharton School
|Gil Van Bokkelen Ph.D.||Co-Founder, Chairman and Chief Executive Officer|
|Robin C. Stracey||Interim Chief Executive Officer and Director|
Cesca Therapeutics Inc.
|Marc H. Hedrick M.D.||Chief Executive Officer, President, Director and Member of Executive Committee|
Cytori Therapeutics, Inc.
|Martin M. McGlynn||Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc|
|Martin P. Rosendale||Chief Executive Officer and Director|
Nuo Therapeutics, Inc.
|$385.0K||Compensation as of Fiscal Year 2014.|